free contador

Enteric Disease Testing Market Will Hit Big Revenues In Future

Comentarios · 24 Vistas

The global enteric disease testing market is estimated to be USD 1.8 billion in 2021; it is projected to grow at a CAGR of 6.0% to reach USD 2.4 billion by 2026. The growth in the enteric disease testing market is attributed to the enforcement of stringent food safety regulations and effec

The global enteric disease testing market is estimated to be USD 1.8 billion in 2021; it is projected to grow at a CAGR of 6.0% to reach USD 2.4 billion by 2026. The growth in the enteric disease testing market is attributed to the enforcement of stringent food safety regulations and effective monitoring of the same by the regulatory authority, increasing level of consumer awareness on food safety and availability of rapid technology with low turnaround time. Lack of infrastructural facilities, high cost of replacement parts, and lack of harmonization act as major restraints for the enteric disease testing market.
 
Enteric Disease Testing Market
 
 
The enteric disease testing market is dominated by few globally established players such as SGS SA (Switzerland), Eurofins Scientific (Luxembourg), Intertek Group plc (UK), Bureau Veritas (France), ALS Limited (Australia) and TÜV SÜD (Germany). These players have adopted growth strategies such as acquisitions, new product launches, and agreements to strengthen their presence in the global market.
 
SGS SA is engaged in the inspection, verification, testing, certification, and quality assurance services. The company has nine business segments—consumer retail; agriculture food life; oil, gas chemical; minerals; industrial; government institution; transportation; certification business enhancement; and environmental health safety. It offers enteric disease testing through its agriculture food life segment. The company operates through a network of more than 2,400 offices and laboratories across Europe, the Middle East, the Americas, Africa, and the Asia Pacific. The company focuses on acquisitions and expansions as its key development strategy to maintain its market leader position and to strengthen its business in different segments. On June 2021, SGS announced the official opening of Its new food testing laboratory in Papua New Guinea, which would offer internationally recognized quality food testing manufacturing, hospitality, and retail market segments. There are many emerging opportunities, which are creating more competitors to the company such as, Eurofins (Luxembourg), Intertek (UK), and Bureau Veritas (France), among others.
 
Eurofins is an international group of laboratories that provide testing and support services to the pharmaceutical, food, environmental, agricultural, and consumer products industries and governments. The company capitalizes on a portfolio of 150,000 reliable analytical methods that enable it to offer services that characterize the safety, identity, purity, composition, authenticity, and origin of products biological substances. It offers testing services through the following 13 divisions—food feed testing, biopharma services, agroscience services, agro testing, clinical diagnostics, cosmetics testing, consumer product testing, forensic services, environmental testing, genomic services, medical devices, Eurofins technologies, and REACH services. It offers enteric disease testing services under its food feed testing division.
 
Eurofins Scientific operates through 800 laboratories in 50 countries, and with such a strong global presence, the company can launch customized solutions for their customers hence the company is identified as a strong player in the enteric disease testing market. The company’s business expansion continues to expand in North America and Europe, along with the focus on expanding and optimizing its laboratory network in the Asia Pacific region. The acquisition of Covance Food Solutions (US) in 2018 allowed the company to strengthen its geographic presence in the North American market.
 
 
The high level of awareness about healthy foods and nutrition is projected to drive the market growth for enteric disease testing market in North American region. Furthermore, the US and Canada combined have a high concentration of market players after Europe and are also high on technology adoption.
Comentarios